Skip to main content

Aby handlować w USA, wejdź na polymarket.us

icon for How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

icon for How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

50 or more 43.5%

35 to 49 43%

20 to 34 5%

Fewer than 20 1.1%

Polymarket

$17,434 Wol.

50 or more 43.5%

35 to 49 43%

20 to 34 5%

Fewer than 20 1.1%

Polymarket

$17,434 Wol.

Fewer than 20

$4,391 Wol.

1%

20 to 34

$8,660 Wol.

5%

35 to 49

$3,069 Wol.

43%

50 or more

$1,315 Wol.

43%

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus activity in New York City this season, with 24 confirmed neuroinvasive cases and 1,737 positive mosquito pools reported by mid-September 2026, forms the core driver behind the near-even market split between 50 or more cases (43%) and 35–49 cases (42%). Record mosquito positivity across all boroughs, compared with prior years, reflects warmer temperatures and extended transmission windows that boost Culex vector abundance and viral amplification in avian reservoirs, consistent with CDC and NYC Health Department surveillance trends showing rising averages from 16–31 neuroinvasive cases annually in recent years. Peak activity typically runs through October, leaving room for additional reports that could push totals higher, though variable late-season weather and control measures introduce uncertainty in final counts.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Wolumen
$17,434
Data zakończenia
Mar 31, 2027
Rynek otwarty
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus activity in New York City this season, with 24 confirmed neuroinvasive cases and 1,737 positive mosquito pools reported by mid-September 2026, forms the core driver behind the near-even market split between 50 or more cases (43%) and 35–49 cases (42%). Record mosquito positivity across all boroughs, compared with prior years, reflects warmer temperatures and extended transmission windows that boost Culex vector abundance and viral amplification in avian reservoirs, consistent with CDC and NYC Health Department surveillance trends showing rising averages from 16–31 neuroinvasive cases annually in recent years. Peak activity typically runs through October, leaving room for additional reports that could push totals higher, though variable late-season weather and control measures introduce uncertainty in final counts.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Wolumen
$17,434
Data zakończenia
Mar 31, 2027
Rynek otwarty
Aug 20, 2026, 5:18 PM ET

Uważaj na linki zewnętrzne.

Często zadawane pytania

"How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" to rynek prognoz na Polymarket z 4 możliwymi wynikami, gdzie traderzy kupują i sprzedają udziały na podstawie tego, co ich zdaniem się wydarzy. Obecny wiodący wynik to "35 to 49" z 43%, za nim "50 or more" z 43%. Ceny odzwierciedlają zbiorowe prawdopodobieństwa w czasie rzeczywistym. Na przykład udział wyceniony na 43¢ implikuje, że rynek zbiorowo przypisuje 43% szansy na ten wynik. Te kursy zmieniają się ciągle, gdy traderzy reagują na nowe informacje. Udziały w poprawnym wyniku można wymienić na $1 za sztukę po rozstrzygnięciu rynku.

Na dzień dzisiejszy "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" wygenerował $17.4K łącznego wolumenu od uruchomienia rynku Aug 20, 2026. Ten poziom aktywności handlowej odzwierciedla silne zaangażowanie społeczności Polymarket i pomaga zapewnić, że bieżące kursy są informowane przez głęboką pulę uczestników rynku. Możesz śledzić ruchy cen na żywo i handlować na dowolny wynik bezpośrednio na tej stronie.

Aby handlować na "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?", przeglądaj 4 dostępnych wyników na tej stronie. Każdy wynik wyświetla bieżącą cenę reprezentującą implikowane prawdopodobieństwo rynku. Aby zająć pozycję, wybierz wynik, który uważasz za najbardziej prawdopodobny, wybierz "Tak", aby handlować na jego korzyść, lub "Nie", aby handlować przeciw niemu, wpisz kwotę i kliknij "Handluj". Jeśli wybrany wynik okaże się poprawny, Twoje udziały "Tak" wypłacą $1 za sztukę. Jeśli jest niepoprawny, wypłacą $0. Możesz też sprzedać swoje udziały w dowolnym momencie przed rozstrzygnięciem.

Obecnym faworytem dla "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" jest "35 to 49" z 43%, co oznacza, że rynek przypisuje 43% szansy na ten wynik. Następny najbliższy wynik to "50 or more" z 43%. Te kursy aktualizują się w czasie rzeczywistym, gdy traderzy kupują i sprzedają udziały, odzwierciedlając najnowszy zbiorowy pogląd na to, co jest najbardziej prawdopodobne. Sprawdzaj regularnie lub dodaj tę stronę do zakładek, aby śledzić zmiany kursów.

Zasady rozstrzygania "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" określają dokładnie, co musi się wydarzyć, aby każdy wynik został ogłoszony zwycięzcą — w tym oficjalne źródła danych używane do ustalenia wyniku. Możesz przejrzeć pełne kryteria rozstrzygania w sekcji "Zasady" na tej stronie nad komentarzami. Zalecamy dokładne zapoznanie się z zasadami przed handlem, ponieważ określają one precyzyjne warunki, przypadki graniczne i źródła regulujące rozstrzyganie tego rynku.